Haematologica (Mar 2016)
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells
- Paola Storti,
- Denise Toscani,
- Irma Airoldi,
- Valentina Marchica,
- Sophie Maiga,
- Marina Bolzoni,
- Elena Fiorini,
- Nicoletta Campanini,
- Eugenia Martella,
- Cristina Mancini,
- Daniela Guasco,
- Valentina Ferri,
- Gaetano Donofrio,
- Franco Aversa,
- Martine Amiot,
- Nicola Giuliani
Affiliations
- Paola Storti
- Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
- Denise Toscani
- Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
- Irma Airoldi
- Laboratorio di Oncologia, Istituto Giannina Gaslini, Genova, Italy
- Valentina Marchica
- Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
- Sophie Maiga
- INSERM, U892, University of Nantes, CNRS, UMR 6299, France
- Marina Bolzoni
- Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
- Elena Fiorini
- Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
- Nicoletta Campanini
- Pathologic Anatomy and Histology, “Azienda Ospedaliero-Universitaria” of Parma, Italy
- Eugenia Martella
- Pathologic Anatomy and Histology, “Azienda Ospedaliero-Universitaria” of Parma, Italy
- Cristina Mancini
- Pathologic Anatomy and Histology, “Azienda Ospedaliero-Universitaria” of Parma, Italy
- Daniela Guasco
- Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
- Valentina Ferri
- Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy;Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy
- Gaetano Donofrio
- Department of Medical-Veterinary Science, University of Parma, Italy
- Franco Aversa
- Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
- Martine Amiot
- INSERM, U892, University of Nantes, CNRS, UMR 6299, France
- Nicola Giuliani
- Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Italy
- DOI
- https://doi.org/10.3324/haematol.2015.133736
- Journal volume & issue
-
Vol. 101,
no. 3
Abstract
No abstracts available.
